Argus Cognitive makes intelligent medical instruments, delivered as SaaS, regulated by the FDA.

We create software medical devices

We develop software medical devices, powered by a proprietary platform of retaskable intelligent algorithms.

Our technology comprehensively quantifies organ-level, system-level and patient-level function

This allows medical professionals to make better, more informed clinical decisions

Our products are regulated as medical devices and are delivered as software as a service

FDA agrees:
software should turn data into
information for doctors

“Artificial intelligence (AI) and machine learning (ML) technologies have the potential to transform health care by deriving new and important insights from the vast amount of data generated during the delivery of health care every day.”
AI/ML-Based Software as a Medical Device (SaMD) Action Plan

This is a new category:

Software as a Medical Device (SaMD)

We develop software medical devices, powered by intelligent algorithms. These algorithms dynamically configure in novel ways to analyze data from existing medical instruments. They generate and measure digital models of organs, systems and/or patients to provide comprehensive, quantified and clinically actionable information. Our products are regulated as medical devices, and are delivered as software as a service.

Too often medical professionals must choose between quantitative data that is limited in scope, and qualitative data that is comprehensive. Our technology delivers quantified, comprehensive information.

Autism, Cardiology and Orthopedics

are the therapy areas Argus is pursuing first

We are working with leading medical institutions to pilot our technology

We have two lead products close to market launch

They are entering the FDA approval process

Our criteria for all products:

Significant clinical need

Efficient development pathway

Superior results relative to existing tech

Products

We have active product development programs that address a variety of important medical areas. Our first two products entering the FDA approval process are:

1. ReVISION Award-winning analysis of right ventricle mechanics to detect and predict a range of debilitating cardiac conditions, such as certain types or heart failure, pulmonary hypertension, and more.

Learn more

2. ARGUS-MDS-ASD (working name): Analysis of social communication skills based on video and audio recordings during scripted psychological interviews to support a) autism diagnosis and b) response to therapy.

Please, feel free to reach out for white papers, publication lists, demos, etc. We love partnerships.

Publications

Behavioral Health publications

  • Predicting the ADOS-2 Calibrated Severity Score From Video And Audio Analysis

    Andras Sarkany, Khaleel Kamal, Emily Dillon, Edith Ocampo, Sarely Licona, Allie Wainer, Latha Soorya, Zoltan Toser

    INSAR - International Society for Autism Research / Annual Meeting

    2021

    Ongoing strides in robust non-intrusive methods allow for the application of computational behavioral assessments in clinical settings, mitigating tedious manual coding processes. Using machine learning components, automated behavioral assessment aims to facilitate the detailed coding of naturalistic behavior (including prosody, facial landmarks, gaze, and pose estimations)...

ReVISION publications

  • ReVISION in outcome prediction

    Contraction Patterns of the Right Ventricle Associated with Different Degrees of Left Ventricular Systolic Dysfunction

    Elena Surkova, Attila Kovács, Márton Tokodi, Bálint Károly Lakatos, Béla Merkely, Denisa Muraru, Alessandro Ruocco, Gianfranco Parati, Luigi P. Badano

    Circulation: Cardiovascular Imaging

    2021

    The functional adaptation of the right ventricle (RV) to the different degrees of left ventricular (LV) dysfunction remains to be clarified. We sought to (1) assess the changes in RV contraction pattern associated with the reduction of LV ejection fraction (EF) and (2) analyze whether the assessment of RV longitudinal, radial, and anteroposterior motion components of total RVEF adds prognostic value.

More cardiology publications

  • Design and validation papers, review articles

    Right ventricular mechanical pattern in health and disease: beyond longitudinal shortening

    Attila Kovács, Bálint Lakatos, Márton Tokodi, Béla Merkely

    Heart Failure Reviews

    2019

    Right ventricular (RV) function has proven to be a prognostic factor in heart failure with reduced and preserved ejection fraction and in pulmonary hypertension. RV function is also a cornerstone in the management of novel clinical issues, such as mechanical circulatory support devices or grown-up congenital heart disease patients...

Team

Argus Cognitive was founded in 2016 by computer scientists, psychologists and a medical device entrepreneur.

  • Zoltan Toser (CEO) and Andras Lorincz (CSO) are computer scientists, specializing in machine learning.

  • Mark Pollack, MD and Latha Soorya, PhD are a practicing psychiatrist and a clinical psychologist.

  • Attila Meretei, MD has been developing medical devices for almost 20 years.

Our product development team is located in Budapest, Hungary.

We maintain a symbiotic relationship with the Neural Information Processing Group at Eotvos Lorand University, Budapest, Hungary, where we can test new technologies before including them in our development pipeline.

In cardiology we closely collaborate with various researchers in the US and Europe.

We are hiring

We are always on the lookout for talented people to join our team. We have openings in the following positions:

Our team is geographically dispersed, present in four continents, so provided you have excellent communication skills, remote work is feasible. Needless to say, good English is a must.

If all this sounds interesting, or you would like more info, don't hesitate to reach out to us at info@arguscognitive.com.

Contact

We have a lot more to say about the company and the team, the unmet need, the market, our technology and products, clinical results and regulatory plans and opportunities in other fields of medicine. If you are interested in a dialogue, collaboration or joining our team, please reach out to us. Thank you!

Zoltan Toser

CEO, Argus Cognitive, Inc.

zoltan@arguscognitive.com

+1 603 322 1944

Attila Meretei, MD

President, Argus Cognitive, Inc.

attila@arguscognitive.com

+1 603 400 2440

Dartmouth Regional Technical Center, 16 Cavendish Court, Lebanon, NH 03766